Development and validation of a prostate cancer risk prediction model for the elevated PSA population
{{output}}
Introduction: To develop and validate a dynamic clinical prediction model integrating prostate-specific antigen (PSA) and peripheral blood biomarkers for distinguishing benign from malignant prostate diseases in patients with ele... ...
